Gilenya Interactions
There are 644 drugs known to interact with Gilenya (fingolimod), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 486 are major, 156 are moderate, and 2 are minor.
- View all 644 medications that may interact with Gilenya
- View Gilenya alcohol/food interactions (1)
- View Gilenya disease interactions (9)
Most frequently checked interactions
View interaction reports for Gilenya (fingolimod) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- amantadine
- amitriptyline
- amlodipine
- Ampyra (dalfampridine)
- atorvastatin
- baclofen
- biotin
- clonazepam
- Cymbalta (duloxetine)
- duloxetine
- gabapentin
- ibuprofen
- levothyroxine
- Lexapro (escitalopram)
- lisinopril
- Lyrica (pregabalin)
- metformin
- modafinil
- multivitamin
- omeprazole
- oxybutynin
- Provigil (modafinil)
- tizanidine
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
Gilenya alcohol/food interactions
There is 1 alcohol/food interaction with Gilenya (fingolimod).
Gilenya disease interactions
There are 9 disease interactions with Gilenya (fingolimod) which include:
- CV disease
- hepatic impairment
- hypertension
- infections
- macular edema
- respiratory dysfunction
- encephalopathy
- MS
- malignancies
Report options
QR code containing a link to this page
More about Gilenya (fingolimod)
- Gilenya consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (95)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
